ENDURING MATERIAL
Risk Assessment in 2026
PREVENT, ApoB, Lp(a), and CAC
Given the breadth and complexity of the 2026 dyslipidemia guidelines, and the well-documented gaps in risk stratification, primary prevention practice, treatment goal attainment, non-statin utilization, and population-specific management, there is a clear and urgent need for education that facilitates translation into clinical practice. Clinicians must not only understand the updated recommendations but also develop the competence and confidence to apply them across diverse patient populations and care settings.
By aligning educational content with documented practice gaps and delivering it in a format that supports sustained engagement, the program aims to improve clinician performance and ultimately enhance patient outcomes. Increased adoption of guideline-recommended practices has the potential to improve lipid control, reduce ASCVD events, and address persistent disparities in cardiovascular care.
Course Activities
-
Pre-TestAssessment Required
-
WebinarContent Required
-
Post-TestAssessment Required
-
EvaluationEvaluation Required
-
Claim CreditCredit claim Required